Literature DB >> 11453543

Adenovirus-mediated expression of pig alpha(1, 3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells.

L Xing1, G H Xia, J Fei, F Huang, L H Guo.   

Abstract

Gal alpha(1, 3) Gal (gal epitope) is a carbohydrate epitope and synthesized in large amount by alpha(1, 3) galactosyltransferase [alpha(1, 3) GT] enzyme on the cells of lower mammalian animals such as pigs and mice. Human has no gal epitope due to the inactivation of alpha(1, 3) GT gene but produces a large amount of antibodies (anti-Gal) which recognize Gal alpha(1, 3) Gal structures specifically. In this study, a replication-deficient recombinant adenoviral vector Ad5sGT containing pig alpha(1, 3) GT cDNA was constructed and characterized. Adenoviral vector-mediated transfer of pig alpha(1, 3) GT gene into human tumor cells such as malignant melanoma A375, stomach cancer SGC-7901, and lung cancer SPC-A-1 was reported for the first time. Results showed that Gal epitope did not increase the sensitivity of human tumor cells to human complement-mediated lysis, although human complement activation and the binding of human IgG and IgM natural antibodies to human tumor cells were enhanced significantly after Ad5sGT transduction. Appearance of gal epitope on the human tumor cells changed the expression of cell surface carbohydrates reacting with Ulex europaeus I (UEA I) lectins, Vicia villosa agglutinin (VVA), Arachis hypogaea agglutinin (PNA), and Glycine max agglutinin (SBA) to different degrees. In addition, no effect of gal epitope on the growth in vitro of human tumor cells was observed in MTT assay.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453543     DOI: 10.1038/sj.cr.7290076

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  4 in total

1.  Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen.

Authors:  Yu Wang; Juan Liao; Ya-Jun Yang; Zhu Wang; Feng Qin; Sheng-Ming Zhu; Hong Zheng; Yan-Ping Wang
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

2.  [Experimental study on A549 cell death mediated by xenoantigen α-gal 
in human serum].

Authors:  Shengming Zhu; Ling Xie; Hong Zheng; Feng Qin; Mei Liu; Zhiguo Luo; Yanping Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-11

3.  Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.

Authors:  Xiaofen Yao; Zhangli Dong; Qiuwan Zhang; Qian Wang; Dongmei Lai
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

Review 4.  Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).

Authors:  Guoli Huai; Ping Qi; Hongji Yang; Yi Wang
Journal:  Int J Mol Med       Date:  2015-10-30       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.